Literature DB >> 18783834

Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression.

Nikolaos Dimopoulos1, Christina Piperi, Vassiliki Psarra, Robert W Lea, Anastasios Kalofoutis.   

Abstract

Oxidative damage and immune-inflammatory activation have been suggested to play a role in depression. The purpose of the study was to investigate possible associations and interactions of these pathophysiological mechanisms in geriatric depression by determining the levels of plasma 8-iso-prostaglandin F(2alpha) (8-iso-PGF(2alpha)) and interleukin-6 (IL-6) in elderly depressed individuals. Subjects over 60 years of age with depression and controls were randomly selected from a population in the community after screening with the Geriatric Depression Scale. Plasma concentrations of 8-iso-PGF2alpha and IL-6 were measured in both groups. Depressed patients had significantly higher mean (+/-S.D.) 8-iso-PGF2alpha levels compared to healthy controls (245.01+/-179.92 pg/ml vs 97.64+/-42.72 pg/ml, respectively). Similarly, the same groups demonstrated significantly elevated IL-6 levels compared with controls (58.73+/-39.90 pg/ml vs 15.41+/-9.27 pg/ml). This study indicates an association between increased levels of plasma 8-iso-PGF2alpha and IL-6 with depressive symptomatology in elderly individuals and indicates the necessity for further investigation, possibly within the framework of an integrated involvement of oxidative damage and inflammation in the pathophysiology of depression in the elderly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18783834     DOI: 10.1016/j.psychres.2007.07.019

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  36 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Depression and oxidative stress: results from a meta-analysis of observational studies.

Authors:  Priya Palta; Laura J Samuel; Edgar R Miller; Sarah L Szanton
Journal:  Psychosom Med       Date:  2013-12-12       Impact factor: 4.312

Review 3.  Current understanding of the neurobiology and longitudinal course of geriatric depression.

Authors:  Sara L Weisenbach; Anand Kumar
Journal:  Curr Psychiatry Rep       Date:  2014-09       Impact factor: 5.285

4.  Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder.

Authors:  Lisa R Steenkamp; Christina M Hough; Victor I Reus; Felipe A Jain; Elissa S Epel; S Jill James; Alexandra E Morford; Synthia H Mellon; Owen M Wolkowitz; Daniel Lindqvist
Journal:  J Affect Disord       Date:  2017-05-06       Impact factor: 4.839

Review 5.  Nitroxidized-Albumin Advanced Glycation End Product and Rheumatoid Arthritis.

Authors:  Akhlas Tarannum; Zarina Arif; Khursheed Alam; Shafeeque Ahmad; Moin Uddin
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

6.  The effect of gender, age, and symptom severity in late-life depression on the risk of all-cause mortality: the Bambuí Cohort Study of Aging.

Authors:  Breno S Diniz; Charles F Reynolds; Meryl A Butters; Mary Amanda Dew; Josélia O A Firmo; Maria Fernanda Lima-Costa; Erico Castro-Costa
Journal:  Depress Anxiety       Date:  2013-12-18       Impact factor: 6.505

Review 7.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

8.  Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress.

Authors:  Gislaine Z Réus; Helena M Abelaira; Amanda L Maciel; Maria Augusta B Dos Santos; Anelise S Carlessi; Amanda V Steckert; Gabriela K Ferreira; Samira D De Prá; Emilio L Streck; Danielle S Macêdo; João Quevedo
Journal:  Metab Brain Dis       Date:  2014-08-13       Impact factor: 3.584

9.  Significance of serum immune markers in identification of global functional impairment in the oldest old: cross-sectional results from the BELFRAIL study.

Authors:  Wim Adriaensen; Catharina Matheï; Gijs van Pottelbergh; Bert Vaes; Delphine Legrand; Pierre Wallemacq; Jean-Marie Degryse
Journal:  Age (Dordr)       Date:  2013-07-03

10.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.